Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Considerations on the appropriateness of the John Cunningham virus antibody assay use in patients with rheumatoid arthritis.
Galectin-9 is Up-regulated in Astrocytes by TNF and Promotes Encephalitogenic T-cell Apoptosis.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Cortical N-acetyl aspartate is a predictor of long-term clinical disability in multiple sclerosis.
Fatigue heralding multiple sclerosis.
Corticosteroids for treating optic neuritis.
Managing patients with neurologic disorders who participate in sports activities.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities.
Interleukin-10 Gene-transfected Mature Dendritic Cells Suppress Murine Experimental Autoimmune Optic Neuritis.
Gene therapy with Mitochondrial Heat Shock Protein 70 Suppresses Visual Loss and Optic Atrophy in Experimental Autoimmune Encephalomyelitis.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
Trace elements in scalp hair samples from patients with relapsing-remitting multiple sclerosis.
Costs of formal and informal home care and quality of life for patients with multiple sclerosis in sweden.
MS14 Down-regulates Lipocalin2 Expression in Spinal Cord Tissue in an Animal Model of Multiple Sclerosis in female C57BL/6.
Cannabinoid modulation of neuroinflammatory disorders.
Your client has multiple sclerosis: understanding the challenge.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Improving multiple sclerosis care: an analysis of the necessity for medication therapy management services among the patient population.
[Chemical constituents from roots of Illicium majus].
Diffuse cauda equina enhancement in a middle aged male with Susac syndrome and symptomatic cauda equina syndrome.
Transplanted microvascular endothelial cells promote oligodendrocyte precursor cell survival in ischemic demyelinating lesions.
Heterogeneous induction of microglia M2a phenotype by central administration of interleukin-4.
Pages
« first
‹ previous
…
473
474
475
476
477
478
479
480
481
…
next ›
last »